Navigation Links
BioMedical Life Systems, Inc. Launches New FDA Cleared Non-Prescription TENS Device
Date:6/6/2013

Vista CA (PRWEB) June 06, 2013

BioMedical Life Systems, Inc. (http://www.bmls.com) makers of Leading Prescription Pain Relief devices for Medical Professionals, serving the durable medical equipment (DME) dealer and distributor market - for over 30 years, has received FDA clearance to market its newest innovation, the REBOUND™ Health TENS device, without a prescription. This launch catapults the company into the newly emerging medical retail environment and enables this time tested technology to now be available directly to the public.

The REBOUND™ Health is a TENS unit (Transcutaneous Electrical Nerve Stimulator) pain relief device that works “through the skin”, transmitting through electrode pads that are attached to the outside of the skin emitting a “tingling sensation” to help manage pain without the use of drugs. Scientific research suggests that the REBOUND™ Health TENS unit (electro-therapy) can be used to relieve chronic or acute pain by blocking the pain signals and triggering a release of endorphins, which provide natural pain relief.

“This is an amazing development in the effort to provide pain relief alternatives without the use of drugs that may potentially have harmful side effects. BioMedical Life Systems, Inc. has always had the philosophy that the option of drug-free pain relief should be available to everyone. Prior to this FDA clearance, the TENS units were only available with a written prescription. Now, TENS unit technology is finally available over-the-counter. We are pleased to see that the government is recognizing this need for change, and taking the necessary steps to enable wider access to the technology”- Mariah Griffith, Vice President of Sales and Marketing for Biomedical Life Systems, Inc.

The REBOUND™ Health (http://www.reboundpainrelief.com) TENS unit is a compact, extremely durable, portable unit measuring 4.9" x 1.4" x .65”, weighs only 1.3 oz. The TENS device is packaged for retail sale with all necessary accessories. The REBOUND™ TENS unit is Effective and Safe-to-Use for Pain Relief from: Hip, Low Back and Mid-Back Pain, Elbow and Wrist Pain, Shoulder and Arm Pain, Knee Pain, Ankle Pain, Joint and Muscle Pains. Simply Surround Your Pain, Power Up and Go! ™.

For further information:
BioMedical Life Systems, Inc.
PO Box 1360, Vista, CA 92085-1360.
http://www.reboundpainrelief.com
E-mail: information(at)bmls(dot)com
Tel: (Toll Free) 1-800-726-8367
Fax: 760-727-4220

Read the full story at http://www.prweb.com/releases/reboundpainrelief/tensunit/prweb10802657.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Ondine Biomedical CEO Carolyn Cross Appointed Treasurer of International Photodynamic Association
2. Arteriocyte announces Launch of Compass Biomedical
3. Regenesis Biomedical Names Scott Brooks Chief Executive Officer
4. Premier Biomedical CEO Interviewed by The Wall Street Transcript
5. ICMs New Blue Gene Supercomputer Supports The Largest Biomedical Research Initiative In Poland
6. New Opportunity: The Biomedical Innovations of Tomorrow - Research Report on PhotoMedex, Axiall Corp, Varian Medical Systems, Volcano Corporation and Navidea Biopharmaceuticals
7. Lupus Research Institute Requests Strengthened NIH Funding for Biomedical Research in Debilitating Diseases like Lupus
8. Fourth Annual Bay Area Biomedical Device Conference: March 27th, 2013 at San Jose State University
9. Foundation for the NIH Announces Lurie Prize Recognizing Outstanding Achievement by a Young Biomedical Scientist
10. ABIA Hires Biomedical Executive, Serial Entrepreneur as Chief Operating Officer
11. Market Outlook: The Future of Biomedical Materials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... ... January 17, 2017 , ... ... of the North American Spine Society (NASS)1 demonstrate high fusion rates at ... cases, when PEEK-OPTIMA™ HA Enhanced is used for interbody-fusion devices. The implantable ...
(Date:1/17/2017)... Jan. 17, 2017  Protagonist Therapeutics, Inc. (NASDAQ: ... has initiated a global Phase 2b induction study ... that targets alpha4beta7 integrin. The aim of this ... evaluate the safety/tolerability and efficacy of PTG-100 in ... to severe active disease. "We ...
(Date:1/16/2017)...  Eurofins Genomics today announced the expansion of its ... receive their primers in a shorter turnaround time, without ... with other providers. Express oligos are available for anyone ... no additional fee. Researchers use the oligos ... sequencing, genotyping, site-directed mutagenesis, and cloning. Often, they are ...
(Date:1/13/2017)... ... January 13, 2017 , ... Two Kalamazoo entrepreneurs have ... fulvic acid that farms, greenhouses and hydroponics operations use to increase yields and ... fastest growing segments of customers using this high grade fulvic acid extracted from ...
Breaking Biology Technology:
(Date:12/7/2016)... Dec. 7, 2016   Veridium , a ... appointment of new CEO James Stickland . ... decades of experience, has served in senior executive ... he specialized in expanding a pipeline of venture ... He most recently served as managing director of ...
(Date:12/6/2016)... Valencell , the leading innovator in performance biometric ... consecutive year of triple digit growth for its PerformTek ... 360 percent increase in companies who have acquired Valencell ... sales of its wrist and ear Benchmark™ sensor systems, ... hearables for fitness and healthcare applications. ...
(Date:12/5/2016)... 2016  The Office of Justice Programs, National ... Scans Enhance or Replace Medico Legal Autopsies?" on ... or replacing forensic autopsies with postmortem X-ray computed ... In response to recommendations made by The National ... scans as a potential component of medicolegal death ...
Breaking Biology News(10 mins):